SG Americas Securities LLC Acquires Shares of 94,032 Enfusion, Inc. (NYSE:ENFN)

SG Americas Securities LLC bought a new position in Enfusion, Inc. (NYSE:ENFN) in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 94,032 shares of the company’s stock, valued at approximately $892,000.

Several other institutional investors have also made changes to their positions in the company. Vanguard Group Inc. grew its holdings in shares of Enfusion by 1.4% during the first quarter. Vanguard Group Inc. now owns 3,653,189 shares of the company’s stock valued at $33,792,000 after buying an additional 51,670 shares in the last quarter. Wasatch Advisors LP grew its stake in Enfusion by 34.2% during the 1st quarter. Wasatch Advisors LP now owns 792,083 shares of the company’s stock valued at $7,327,000 after acquiring an additional 201,771 shares in the last quarter. Scalar Gauge Management LLC increased its holdings in shares of Enfusion by 21.8% in the 2nd quarter. Scalar Gauge Management LLC now owns 613,513 shares of the company’s stock valued at $5,227,000 after purchasing an additional 110,000 shares during the period. Dimensional Fund Advisors LP lifted its position in shares of Enfusion by 57.5% in the second quarter. Dimensional Fund Advisors LP now owns 524,142 shares of the company’s stock worth $4,466,000 after purchasing an additional 191,436 shares in the last quarter. Finally, Wellington Management Group LLP boosted its holdings in shares of Enfusion by 5.7% during the fourth quarter. Wellington Management Group LLP now owns 489,364 shares of the company’s stock worth $4,747,000 after purchasing an additional 26,464 shares during the period. 81.05% of the stock is owned by hedge funds and other institutional investors.

Enfusion Stock Performance

Shares of ENFN opened at $8.99 on Friday. The company has a market capitalization of $1.15 billion, a PE ratio of 224.81, a PEG ratio of 2.49 and a beta of 0.92. The company’s 50 day moving average price is $8.49 and its 200 day moving average price is $8.89. Enfusion, Inc. has a 52 week low of $7.52 and a 52 week high of $10.45.

Enfusion (NYSE:ENFN) last posted its quarterly earnings results on Tuesday, August 6th. The company reported $0.02 EPS for the quarter, missing the consensus estimate of $0.03 by ($0.01). Enfusion had a net margin of 1.98% and a return on equity of 6.17%. The company had revenue of $49.46 million for the quarter, compared to analysts’ expectations of $50.27 million. On average, equities analysts forecast that Enfusion, Inc. will post 0.07 earnings per share for the current fiscal year.

Enfusion Company Profile

Enfusion, Inc provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company provides Portfolio Management System, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and Order and Execution Management System that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines.